37,718 Shares in Humana Inc. $HUM Acquired by PDT Partners LLC

PDT Partners LLC bought a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, HoldingsChannel.com reports. The firm bought 37,718 shares of the insurance provider’s stock, valued at approximately $14,982,000. Humana makes up 0.8% of PDT Partners LLC’s portfolio, making the stock its 20th largest position.

Several other hedge funds and other institutional investors have also bought and sold shares of HUM. Montag A & Associates Inc. raised its position in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Humana during the 2nd quarter worth $26,000. Fideuram Asset Management Ireland dac bought a new stake in Humana during the fourth quarter valued at about $27,000. Trust Co. of Vermont bought a new stake in Humana during the second quarter valued at about $28,000. Finally, Reflection Asset Management purchased a new position in Humana in the fourth quarter valued at about $29,000. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM stock opened at $388.92 on Wednesday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market capitalization of $46.70 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.20 and a beta of 0.72. The stock’s 50-day simple moving average is $383.88 and its 200-day simple moving average is $285.00.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue was up 26.2% on a year-over-year basis. During the same period last year, the firm posted $6.27 EPS. As a group, equities analysts forecast that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HUM shares. Seaport Research Partners downgraded shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Humana in a research report on Thursday, July 30th. They issued a “hold” rating on the stock. UBS Group assumed coverage on shares of Humana in a research note on Thursday, July 30th. They set a “buy” rating for the company. Finally, Robert W. Baird set a $390.00 target price on shares of Humana in a research report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.